"L'Ospedale Policlinico San Martino è da sempre un punto di riferimento per le necessità sanitarie dei cittadini dell'area metropolitana genovese e ligure. In cinque secoli di storia l'alto livello e la qualità delle prestazioni offerte hanno richiamato utenti da tutta Italia e dall'estero, contribuendo a rendere questa struttura un importante centro di riferimento."

During the past decade, IRCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11°piano- lato ponente conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 2 clinical trials were completed, i.e. on average, 22.2% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "IRCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11°piano- lato ponente" #1 collaborator was "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 3 trials as a collaborator, "Janssen Pharmaceutica" with 1 trials as a collaborator, "Janssen-Cilag Ltd." with 1 trials as a collaborator and "Study Alliance Leukemia (SAL) Group" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "IRCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11°piano- lato ponente" are "Chronic Myeloid Leukemia" (3 trials), "Follicular Lymphoma" (3 trials), "Leukemia" (3 trials), "Acute Promyelocytic Leukemia" (2 trials) and "BCR-ABL Positive" (2 trials). Many other conditions were trialed in "IRCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11°piano- lato ponente" in a lesser frequency.

Most popular intervention types in "IRCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11°piano- lato ponente" are "Drug" (21 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nilotinib" (2 trials), "all-trans retinoic acid (ATRA)" (2 trials), "mercaptopurine" (2 trials), "methotrexate" (2 trials) and "Alentuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "IRCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11°piano- lato ponente" are 26 trials for "All" genders.

Currently, there are NaN active trials in "IRCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11°piano- lato ponente". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in IRCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11°piano- lato ponente, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in IRCCS_AOU San Martino-IST-Ematologia 1-Monoblocco 11°piano- lato ponente, 1 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".